XFREE
Live / Registered — Registered (as of 11 Jan 2022)
What this means for you
Registered since 11 Jan 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90207345
- Registration number
- 6616598
- Mark type
- Stylized text
- Filed
- 24 Sept 2020
- Published for opposition
- 27 Apr 2021
- Registered
- 11 Jan 2022
- Attorney of record
- Mark P Kahler
Goods and services
- Class 001 — Chemicals: Reagents, namely, reagents for medical research testing or for scientific research use; molecular reagents, namely, lyophilized reagents for chemical testing purposes in scientific research; molecular reagents, namely, custom lyophilized reagents for chemical testing for scientific or medical research purposes; molecular reagents, namely, lyophilized reagents for chemical testing purposes, namely, for clinical laboratory use, food safety testing, pharmaceutical testing and water quality analysis for scientific research purposes; molecular reagents, namely, molecular diagnostic reagents for scientific or research use in connection with genetic materials; molecular reagents, namely, molecular reagents for use in real-time PCR and nucleic sequencing platforms for scientific or medical research use
- Class 005 — Pharmaceuticals: Medical diagnostic tests for infectious and genetic diseases; medical diagnostic tests including reagents to test for infectious and genetic diseases; medical diagnostic tests employing polymerase chain reaction (PCR) to test for infectious and genetic diseases; reagents, namely, reagents for medical diagnostic testing use; molecular reagents, namely, lyophilized reagents for chemical testing purposes for medical or veterinary use; molecular reagents, namely, custom lyophilized reagents for chemical testing purposes for medical or veterinary use; molecular reagents, namely, lyophilized reagents for chemical testing purposes, namely, clinical medical reagents and chemical reagents for medicinal pharmaceutical use; molecular reagents, namely, molecular reagents for medical diagnostic use in connection with genetic materials; molecular reagents, namely, molecular reagents for medical diagnostic use in real-time PCR and nucleic sequencing platforms
Owner
- BioGX, Inc., Birmingham, AL, US
- BioGX, Inc., Birmingham, AL, US
- BioGX, Inc., Birmingham, AL, US
Prosecution history
- 11 Jan 2022 — REGISTERED-PRINCIPAL REGISTER
- 07 Dec 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Dec 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Dec 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Nov 2021 — USE AMENDMENT FILED
- 04 Dec 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Nov 2021 — TEAS STATEMENT OF USE RECEIVED
- 22 Jun 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Apr 2021 — PUBLISHED FOR OPPOSITION
- 07 Apr 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Mar 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Mar 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Mar 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED